According to a Reuters report, a spokeswomen from the FDA said yesterday that, “There is not going to be an additional advisory committee meeting” about the current application for the approval of Provenge. The FDA has the right to convene another meeting to discuss the results of the IMPACT trial, but it now looks as [...]
Currently, there is “Dear Colleague Letter” being circulated by two members of the U.S. House of Representatives, Jim Marshall (GA) and Peter King (NY) asking for support for increased funding for the Prostate Cancer Research Program (PCRP) — part of the Congressionally Directed Medical Research Program at the Department of Defense. The letters are circulated [...]
We have had fish oil on our must consume list for many years, now there might be some additional data confirming this long known recommendation. Research published in the March 2010 print edition of the FASEB Journal reports that scientists have show that the omega-3 fatty acid, “docosahexaenoic acid” or “DHA,” and its derivatives in [...]
We know that docetaxel chemotherapy (chemo) extends life, but which men might hope to experience an increase in survival? The Department of Urology, All India Institute of Medical Sciences, New Delhi, India performed a small study designed to evaluate the efficacy of docetaxel/prednisone and zoledronic acid in the treatment of men with hormone refractory prostate [...]
In a Town Hall discussion, “Ablating Testosterone in Prostate Cancer and the Concomitant Negative Effects”, Fred Saad, MD, FRCS, Director of Urologic Oncology, Professor of Surgery/Urology, U of M Chair in Prostate Cancer; University of Montreal discussed the negative effects that bone loss resulting from hormone therapy (ADT) poses to our life expectancy. His over [...]